QQ客服 官方微博 反馈留言

	Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants
	Yang, J.; Chen, K.; Zhang, G.; Yang, Q.-Y.; Li, Y.-S.; Huang, S.-Z.; Wang, Y.-L.; Yang, W.; Jiang, X.-J.; Yan, H.-X.
刊名	European Journal of Medicinal Chemistry
	2018
卷号	Vol.143页码:1148-1164
关键词	Drug resistance mutant Medullary thyroid cancer RET kinase Structure-activity relationship
ISSN号	0223-5234
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1821703
专题	四川大学
作者单位	1.Department of Clinical Medicine, School of Medicine, Nankai University, Tianjin, China 2.a State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University/Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan, China 3.Key Laboratory of Drug Targeting and Drug Delivery System of Ministry of Education, West China School of Pharmacy, Sichuan University, Sichuan, China
推荐引用方式 GB/T 7714	Yang, J.,Chen, K.,Zhang, G.,et al. Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants[J]. European Journal of Medicinal Chemistry,2018,Vol.143:1148-1164.
APA	Yang, J..,Chen, K..,Zhang, G..,Yang, Q.-Y..,Li, Y.-S..,...&Yang, S.-Y..(2018).Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants.European Journal of Medicinal Chemistry,Vol.143,1148-1164.
MLA	Yang, J.,et al."Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants".European Journal of Medicinal Chemistry Vol.143(2018):1148-1164.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。